Billion dollar babies-biotech drugs as blockbusters
Article Abstract:
The biotech drugs like the HIV drug-Atripla, HPV vaccine, monoclonal antibodies for cancer treatment are fetching tremendous revenues and have attained a biopharmaceutical blockbuster status. The biotech industry aims to target broad-based markets with a large patient population.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Crystal gazing: Biotech's financial outlook
Article Abstract:
A leading biotechnology analyst has given his views on the future of the biotechnology industry. Biotechnology is a research and development driven enterprise and hence investors should pay more attention to management compensation in the future.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Getting dumped
Article Abstract:
Industry insiders have provided some alternatives for the best practice when a product is returned or discontinued by a licensee.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Covering the spectrum. Getting tough. The case for consolidation
- Abstracts: Insights into US public biotech sector using patenting trends. Navigating the future(s) of biotech intellectual property
- Abstracts: The policy outlook from the Hill. Action needed to harmonize regulation of low-level presence of biotech traits